| (S)-nicotine | multiple interactions | ISO | RGD:730889 | 6480464 | Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of PRKAA2 protein]; more ... | CTD | PMID:17635921 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of PRKAA2 mRNA | CTD | PMID:22265867 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:730889 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:730889 | 6480464 | Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] | CTD | PMID:16990341 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PRKAA2 mRNA | CTD | PMID:20068009 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases phosphorylation | ISO | RGD:730889 | 6480464 | Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein | CTD | PMID:16990341 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:730889 | 6480464 | Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] | CTD | PMID:16990341 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:730889 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:730889 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRKAA2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA | CTD | PMID:22298810 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 protein]; more ... | CTD | PMID:21454484 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | increases phosphorylation | ISO | RGD:730888 | 6480464 | AICA ribonucleotide results in increased phosphorylation of PRKAA2 protein | CTD | PMID:18482975 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:730888 | 6480464 | PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA] | CTD | PMID:21205922 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]] | CTD | PMID:15806154 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:730889 | 6480464 | [AICA ribonucleotide results in increased activity of PRKAA2 protein] which results in decreased activity of FASN protein | CTD | PMID:17635921 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | increases activity | ISO | RGD:730889 | 6480464 | AICA ribonucleotide results in increased activity of PRKAA2 protein | CTD | PMID:17635921 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:730888 | 6480464 | AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA2 protein | CTD | PMID:16873680 |
| aflatoxin B1 | increases expression | ISO | RGD:730889 | 6480464 | Aflatoxin B1 results in increased expression of PRKAA2 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | ISO | RGD:730888 | 6480464 | Aflatoxin B1 results in increased expression of PRKAA2 mRNA | CTD | PMID:22100608 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PRKAA2 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:730889 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PRKAA2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:730889 | 6480464 | Benzo(a)pyrene results in decreased expression of PRKAA2 mRNA | CTD | PMID:22228805 |
| cadmium sulfate | multiple interactions | ISO | RGD:730889 | 6480464 | cadmium sulfate affects the reaction [MTF1 affects the expression of PRKAA2 mRNA] | CTD | PMID:16221973 |
| caffeine | increases expression | EXP | | 6480464 | Caffeine results in increased expression of PRKAA2 mRNA | CTD | PMID:22583948 |
| carmustine | affects response to substance | ISO | RGD:730888 | 6480464 | PRKAA2 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PRKAA2 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PRKAA2 mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | increases expression | ISO | RGD:730888 | 6480464 | Copper Sulfate results in increased expression of PRKAA2 mRNA | CTD | PMID:19549813 |
| D-glucose | multiple interactions | ISO | RGD:730889 | 6480464 | Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein | CTD | PMID:19052259 |
| D-glucose | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] | CTD | PMID:23090186 |
| D-glucose | multiple interactions | ISO | RGD:730888 | 6480464 | Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein; more ... | CTD | PMID:18482975 |
| D-glucose | affects response to substance | EXP | | 6480464 | PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency | CTD | PMID:15806154 |
| D-glucose | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]] | CTD | PMID:15806154 |
| Delta(9)-tetrahydrocannabinol | increases activity | EXP | | 6480464 | Tetrahydrocannabinol results in increased activity of PRKAA2 protein | CTD | PMID:15899896 |
| dibutyl phthalate | increases expression | ISO | RGD:730889 | 6480464 | Dibutyl Phthalate results in increased expression of PRKAA2 mRNA | CTD | PMID:21266533 |
| glucose | multiple interactions | ISO | RGD:730889 | 6480464 | Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein | CTD | PMID:19052259 |
| glucose | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] | CTD | PMID:23090186 |
| glucose | multiple interactions | ISO | RGD:730888 | 6480464 | Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein; more ... | CTD | PMID:18482975 |
| glucose | affects response to substance | EXP | | 6480464 | PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency | CTD | PMID:15806154 |
| glucose | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]] | CTD | PMID:15806154 |
| histamine | multiple interactions | ISO | RGD:730888 | 6480464 | [PRKAA1 protein co-treated with PRKAA2 protein] affects the reaction [Histamine results in increased phosphorylation of NOS2 protein] | CTD | PMID:21145922 |
| mercury dichloride | decreases expression | ISO | RGD:730889 | 6480464 | Mercuric Chloride results in decreased expression of PRKAA2 mRNA | CTD | PMID:22019852 |
| metformin | multiple interactions | ISO | RGD:730888 | 6480464 | Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein | CTD | PMID:16873680 |
| metformin | increases phosphorylation | EXP | | 6480464 | Metformin results in increased phosphorylation of PRKAA2 protein | CTD | PMID:19594306 |
| metformin | increases activity | EXP | | 6480464 | Metformin results in increased activity of PRKAA2 protein | CTD | PMID:18484962 |
| metformin | affects response to substance | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the susceptibility to Metformin | CTD | PMID:20847317 |
| metformin | multiple interactions | ISO | RGD:730889 | 6480464 | Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein | CTD | PMID:19052259 |
| metformin | multiple interactions | EXP | | 6480464 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein] | CTD | PMID:21186350 |
| metformin | increases activity | ISO | RGD:730889 | 6480464 | Metformin results in increased activity of PRKAA2 protein | CTD | PMID:17635921 |
| metformin | multiple interactions | ISO | RGD:730889 | 6480464 | [Metformin results in increased activity of PRKAA2 protein] which results in decreased activity of FASN protein | CTD | PMID:17635921 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730889 | 6480464 | Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of PRKAA2 protein] | CTD | PMID:17635921 |
| nicotinamide | multiple interactions | ISO | RGD:730888 | 6480464 | Niacinamide inhibits the reaction [6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of PRKAA2 protein] | CTD | PMID:18482975 |
| nicotinic acid | increases activity | ISO | RGD:730888 | 6480464 | Niacin results in increased activity of PRKAA2 protein | CTD | PMID:14749208 |
| paracetamol | affects expression | ISO | RGD:730889 | 6480464 | Acetaminophen affects the expression of PRKAA2 mRNA | CTD | PMID:17562736 |
| peroxynitrous acid | multiple interactions | ISO | RGD:730889 | 6480464 | [Nicotine promotes the reaction [Peroxynitrous Acid results in increased activity of PRKAA2 protein]] which results in increased phosphorylation of FASN protein; more ... | CTD | PMID:17635921 |
| phenobarbital | decreases expression | ISO | RGD:730889 | 6480464 | Phenobarbital results in decreased expression of PRKAA2 mRNA | CTD | PMID:23091169 |
| pirinixic acid | increases expression | ISO | RGD:730889 | 6480464 | pirinixic acid results in increased expression of PRKAA2 mRNA | CTD | PMID:18301758 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PRKAA2 mRNA | CTD | PMID:19236843 |
| resveratrol | multiple interactions | ISO | RGD:730888 | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of PRKAA2 protein | CTD | PMID:16873680 |
| resveratrol | multiple interactions | ISO | RGD:730888 | 6480464 | PRKAA2 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; more ... | CTD | PMID:18482975 |
| resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] | CTD | PMID:23090186 |
| resveratrol | affects response to substance | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the susceptibility to resveratrol | CTD | PMID:23090186 |
| resveratrol | increases phosphorylation | ISO | RGD:730888 | 6480464 | resveratrol results in increased phosphorylation of PRKAA2 protein | CTD | PMID:18482975 PMID:20080969 |
| resveratrol | decreases expression | ISO | RGD:730889 | 6480464 | resveratrol results in decreased expression of PRKAA2 mRNA | CTD | PMID:22610192 |
| resveratrol | decreases activity | ISO | RGD:730889 | 6480464 | resveratrol results in decreased activity of PRKAA2 protein | CTD | PMID:19934007 |
| resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein promotes the reaction [resveratrol results in increased expression of UCP1 mRNA]; more ... | CTD | PMID:19934007 |
| resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | STK11 protein promotes the reaction [resveratrol results in increased phosphorylation of PRKAA2 protein] | CTD | PMID:17438283 |
| resveratrol | increases phosphorylation | ISO | RGD:730889 | 6480464 | resveratrol results in increased phosphorylation of PRKAA2 protein | CTD | PMID:17438283 |
| resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of PRKAA2 protein | CTD | PMID:17464184 |
| resveratrol | increases phosphorylation | ISO | RGD:730888 | 6480464 | resveratrol results in increased phosphorylation of PRKAA2 protein | CTD | PMID:20080969 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Dietary Fats results in decreased expression of PRKAA2 mRNA] | CTD | PMID:21034554 |
| sulindac | multiple interactions | EXP | | 6480464 | [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKAA2 mRNA | CTD | PMID:20371263 |
| temozolomide | affects response to substance | ISO | RGD:730888 | 6480464 | PRKAA2 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| testosterone enanthate | affects expression | ISO | RGD:730888 | 6480464 | testosterone enanthate affects the expression of PRKAA2 mRNA | CTD | PMID:17440010 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of PRKAA2 mRNA | CTD | PMID:12734012 |
| tetrachloromethane | affects expression | ISO | RGD:730889 | 6480464 | Carbon Tetrachloride affects the expression of PRKAA2 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA | CTD | PMID:16239168 |
| trans-resveratrol | multiple interactions | ISO | RGD:730888 | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of PRKAA2 protein | CTD | PMID:16873680 |
| trans-resveratrol | multiple interactions | ISO | RGD:730888 | 6480464 | PRKAA2 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; more ... | CTD | PMID:18482975 |
| trans-resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] | CTD | PMID:23090186 |
| trans-resveratrol | affects response to substance | ISO | RGD:730889 | 6480464 | PRKAA2 protein affects the susceptibility to resveratrol | CTD | PMID:23090186 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:730888 | 6480464 | resveratrol results in increased phosphorylation of PRKAA2 protein | CTD | PMID:18482975 PMID:20080969 |
| trans-resveratrol | decreases expression | ISO | RGD:730889 | 6480464 | resveratrol results in decreased expression of PRKAA2 mRNA | CTD | PMID:22610192 |
| trans-resveratrol | decreases activity | ISO | RGD:730889 | 6480464 | resveratrol results in decreased activity of PRKAA2 protein | CTD | PMID:19934007 |
| trans-resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | PRKAA2 protein promotes the reaction [resveratrol results in increased expression of UCP1 mRNA]; more ... | CTD | PMID:19934007 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:730888 | 6480464 | resveratrol results in increased phosphorylation of PRKAA2 protein | CTD | PMID:20080969 |
| trans-resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of PRKAA2 protein | CTD | PMID:17464184 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:730889 | 6480464 | resveratrol results in increased phosphorylation of PRKAA2 protein | CTD | PMID:17438283 |
| trans-resveratrol | multiple interactions | ISO | RGD:730889 | 6480464 | STK11 protein promotes the reaction [resveratrol results in increased phosphorylation of PRKAA2 protein] | CTD | PMID:17438283 |
| valproic acid | increases expression | ISO | RGD:730888 | 6480464 | Valproic Acid results in increased expression of PRKAA2 mRNA | CTD | PMID:19101580 |
| valproic acid | increases expression | ISO | RGD:730889 | 6480464 | Valproic Acid results in increased expression of PRKAA2 mRNA | CTD | PMID:22045034 |
| vancomycin | increases expression | ISO | RGD:730889 | 6480464 | Vancomycin results in increased expression of PRKAA2 mRNA | CTD | PMID:18930951 |